Myfortic and CellCept side effects associated with Progressive Multifocal Leukoencephalopathy
The warnings labels for Myfortic and CellCept have been updated to include information about a potential risk of a Progressive Multifocal Leukoencephalopathy, also known as PML or Progressive Multifocal Leukoencephalitis. The rare neurological disease is often fatal, and there is no known cure.
Myfortic (metobolite mycophenolic acid) and CellCept (mycophenolate mofetil) are medications that are often prescribed following an organ transplant to prevent the body from rejecting the organ. The drugs already carry a blackbox warning that was added in November 2007 about a risk of birth defects when takne by pregnant women.
>>PRIOR POST (10/29/2007): FDA Warns About CellCept Birth Defects
Progressive Multifocal Leukoencephalopathy is a very rare condition which has only been reported in about 20 patients treated with the drug, but given the high fatality rate information was added to the Warnings and Adverse Reactions section about the postmarketing data.
The viral neurological disease has no known cure and causes progressive damage to the brain. Symptoms of PML as a side effect of CellCept or Myfortic could include:
- Weakness or Paralysis
- Vision Changes
- Loss of Coordination
- Memory Loss
- Difficulty Talking
- Trouble Understanding Others
MYFORTIC AND CELLCEPT LAWSUITS
The lawyers at Saiontz & Kirk, P.A. are reviewing the potential for legal claims for individuals who have been diagnosed with Progressive Multifocal Leukoencepalopathy (PML) after taking one of the immunosuppressant medications. Myfortic and CellCept lawsuits are also being evaluated on behalf of children who suffered birth defects, such as cleft palate, cleft lip and ear deformities, after the mother took the drug during pregnancy.
To review a potential lawsuit and determine if financial compensation may be available, request a free consultation and claim evaluation.
